X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
index medicus (12) 12
aged (11) 11
male (11) 11
middle aged (11) 11
female (10) 10
asthma (9) 9
chronic obstructive pulmonary disease (8) 8
administration, inhalation (7) 7
adrenal cortex hormones - administration & dosage (6) 6
adult (6) 6
aged, 80 and over (6) 6
asthma - drug therapy (6) 6
mortality (6) 6
respiratory system (6) 6
studies (6) 6
cohort studies (5) 5
pharmacology & pharmacy (5) 5
retrospective studies (5) 5
risk factors (5) 5
united states (5) 5
androstadienes - administration & dosage (4) 4
cluster analysis (4) 4
corticosteroids (4) 4
patients (4) 4
pneumonia (4) 4
treatment outcome (4) 4
1506 (3) 3
1731 (3) 3
adolescent (3) 3
adrenal cortex hormones - therapeutic use (3) 3
adrenergic beta-2 receptor agonists - administration & dosage (3) 3
albuterol - administration & dosage (3) 3
albuterol - analogs & derivatives (3) 3
analysis (3) 3
bronchodilator agents - therapeutic use (3) 3
copd (3) 3
disease progression (3) 3
drug therapy (3) 3
epidemiology (3) 3
hospitalization (3) 3
inhaled corticosteroids (3) 3
lung diseases (3) 3
lung diseases, obstructive (3) 3
management (3) 3
medicine, general & internal (3) 3
phenotypes (3) 3
pulmonary disease, chronic obstructive - drug therapy (3) 3
pulmonary disease, chronic obstructive - physiopathology (3) 3
research (3) 3
respiratory medicine (3) 3
salmeterol xinafoate (3) 3
time factors (3) 3
young adult (3) 3
1692 (2) 2
adrenergic alpha-antagonists - therapeutic use (2) 2
adrenergic beta-2 receptor agonists - adverse effects (2) 2
age factors (2) 2
agonists (2) 2
albuterol - therapeutic use (2) 2
algorithms (2) 2
allergy (2) 2
androstadienes - therapeutic use (2) 2
anti-asthmatic agents - administration & dosage (2) 2
asthma - mortality (2) 2
asthma - physiopathology (2) 2
benefit-risk (2) 2
benign prostatic hyperplasia (2) 2
benzyl alcohols - administration & dosage (2) 2
bronchodilator agents - administration & dosage (2) 2
cardiovascular disease (2) 2
child (2) 2
child, preschool (2) 2
chlorobenzenes - administration & dosage (2) 2
clinical medicine (2) 2
clinical trials (2) 2
community-acquired pneumonia (2) 2
comorbidity (2) 2
cost-benefit analysis (2) 2
databases, factual (2) 2
death (2) 2
diseases of the respiratory system (2) 2
diuretics (2) 2
double-blind (2) 2
drug combinations (2) 2
drug therapy, combination (2) 2
electronic health records (2) 2
exacerbations (2) 2
fluticasone-salmeterol drug combination (2) 2
health aspects (2) 2
health economics (2) 2
hospitalization - statistics & numerical data (2) 2
impact (2) 2
inhaled corticosteroid (2) 2
internet (2) 2
lung-function (2) 2
markov chains (2) 2
medical informatics (2) 2
medicine & public health (2) 2
moderate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ Open, ISSN 2044-6055, 07/2014, Volume 4, Issue 7, pp. e005540 - e005540
Objectives The optimal method of identifying people with chronic obstructive pulmonary disease (COPD) from electronic primary care records is not known. We... 
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PRIMARY-CARE | ALGORITHMS | COPD | Algorithms | Humans | Middle Aged | Pulmonary Disease, Chronic Obstructive | Biomedical Research | Female | Male | Aged | Primary Health Care | Electronic Health Records | Databases, Factual
Journal Article
Thorax, ISSN 0040-6376, 12/2014, Volume 69, Issue Suppl 2, pp. A182 - A182
Introduction and objectives ICS of differing particle size, due both to the formulation and propellant, may impact patient outcomes. This systematic review of... 
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2016, Volume 112, pp. 88 - 96
Abstract Background Current evidence suggests that blood eosinophil levels (Eos) are associated with chronic obstructive pulmonary disease (COPD) treatment... 
Pulmonary/Respiratory | Biomarkers | Chronic obstructive pulmonary disease | NHANES | Eosinophils | CARDIAC & CARDIOVASCULAR SYSTEMS | NATIONAL-HEALTH | NUTRITION EXAMINATION | PHENOTYPES | PREVALENCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | INFLAMMATION | EXACERBATIONS | LUNG-DISEASE | ASTHMA | Multivariate Analysis | United States - epidemiology | Prevalence | Age Factors | Nutrition Surveys | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Eosinophilia - epidemiology | Eosinophils - immunology | Pulmonary Disease, Chronic Obstructive - epidemiology | Case-Control Studies | Forced Expiratory Volume | Rhinitis, Allergic, Seasonal - epidemiology | Overweight - epidemiology | Asthma - immunology | Adult | Female | Heart Failure - epidemiology | Asthma - epidemiology | Severity of Illness Index | Asthma - physiopathology | Cross-Sectional Studies | Logistic Models | Eosinophilia - immunology | Obesity - epidemiology | Sex Factors | Aged | Pulmonary Disease, Chronic Obstructive - immunology | Cohort Studies | Epidemiology | Lung diseases, Obstructive | Hypertension | Heart failure | Food allergies | Heart attacks | Lung diseases | Cardiovascular disease | Blood | Morbidity | Hay fever | Studies | Body mass index | Ethnicity | Population | Diabetes | Emphysema | Smoking
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e97149
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 05/2014, Volume 9, pp. 457 - 468
Journal Article
Journal Article
Pneumologie, ISSN 0934-8387, 02/2016, Volume 70, Issue S 01
Rationale: Die Reduktion von Exazerbationen ist ein Therapieerfolg bei der Behandlung der COPD. Diese Analyse soll Patienten identifizieren, die dadurch von... 
Conference Proceeding
Drug Safety, ISSN 0114-5916, 6/2011, Volume 34, Issue 6, pp. 511 - 520
Background: An association between salmeterol, a long-acting β2-agonist (LABA), use and rare serious asthma events or asthma mortality was observed in two... 
Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Guideline-utilisation | Prescribing | Bronchodilators | Beta-2-adrenergic-receptor-agonists | Salmeterol | Asthma | LONG-ACTING BETA-AGONISTS | INHALED CORTICOSTEROIDS | RISK | ILLNESS | DEATH RATES | AGONISTS | BETA-2-AGONISTS | CARE | HOSPITALIZATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PHARMACOLOGY & PHARMACY | TOXICOLOGY | ENGLAND | Humans | Middle Aged | Child, Preschool | Prescriptions - statistics & numerical data | Fluticasone | Adrenal Cortex Hormones - therapeutic use | Young Adult | Anti-Inflammatory Agents - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Albuterol - administration & dosage | General Practice | Aged, 80 and over | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Retrospective Studies | Child | Salmeterol Xinafoate | Administration, Inhalation | Albuterol - analogs & derivatives | United Kingdom | Asthma - drug therapy | Drug Therapy, Combination - methods | Adolescent | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Androstadienes - therapeutic use | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Cohort Studies | Prescription writing | Family medicine | Forecasts and trends | Dosage and administration | Drug therapy | Asthmatics
Journal Article
Journal Article
Therapeutic Innovation & Regulatory Science, ISSN 2168-4790, 5/2015, Volume 49, Issue 3, pp. 377 - 386
Background: This cross-sectional survey describes attitudes and reading behaviors toward medication guides among 785 subjects with migraine, asthma, or COPD... 
survey | medication | Treximet | Advair | safety | INTERNET | MEDICAL INFORMATICS | CONSUMER HEALTH INFORMATION | PHARMACOLOGY & PHARMACY | PRESCRIPTION DRUG INFORMATION | READABILITY | Studies | Prescription drugs | Authorship | Migraine | Questionnaires | Headaches | Chronic obstructive pulmonary disease | Pharmaceutical industry | Drug stores | Patients | Asthma | Printed materials
Journal Article